Given the steady increase in the use of oral antidiabetic medication, better knowledge of their effects on neonatal outcomes in gestational diabetes mellitus is essential. Recently, Marie-Victoire Sénat and colleagues investigated the use of glyburide over standard insulin treatment in a noninferiority multicentre randomized trial, which found higher risk of perinatal complications under glyburide therapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gestationsdiabetes (GDM) (Update 2023)
Wiener klinische Wochenschrift Open Access 01 January 2023
-
Gestationsdiabetes (GDM) (Update 2019)
Wiener klinische Wochenschrift Open Access 12 April 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kautzky-Willer, A., Harreiter, J. & Pacini, G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr. Rev. 37, 278–316 (2016).
National Collaborating Centre for Women’s and Children’s Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. In: National Institute for Health and Care Excellence (National Collaborating Centre for Women’s and Children’s Health (UK), London, 2015).
Egan, A. M. et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia 60, 1913–1921 (2017).
Agha-Jaffar, R., Oliver, N., Johnston, D. & Robinson, S. Gestational diabetes mellitus: does an effective prevention strategy exist? Nat. Rev. Endocrinol. 12, 533–546 (2016).
Blumer, I. et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98, 4227–4249 (2013).
American Diabetes, A. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care 41, S137–S143 (2018).
Senat, M. V. et al. Effect of glyburide versus subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial. JAMA 319, 1773–1780 (2018).
Song, R. et al. Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis. PLoS ONE 12, e0182488 (2017).
Balsells, M. et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350, h102 (2015).
Adamkin, D. H. Neonatal hypoglycemia. Semin. Fetal Neonatal Med. 22, 36–41 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kautzky-Willer, A., Harreiter, J. Needle beats pill in gestational diabetes mellitus. Nat Rev Endocrinol 14, 448–449 (2018). https://doi.org/10.1038/s41574-018-0050-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-018-0050-0
This article is cited by
-
Gestationsdiabetes (GDM) (Update 2023)
Wiener klinische Wochenschrift (2023)
-
Gestationsdiabetes (GDM) (Update 2019)
Wiener klinische Wochenschrift (2019)